All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.
The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Introducing
Now you can personalise
your MPN Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe MPN Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the MPN Hub cannot guarantee the accuracy of translated content. The MPN Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
How can we predict and reduce the risk of thrombosis in a patient with PV?
Bookmark this article
During the 2020 Annual Meeting of the Society of Hematologic Oncology (SOHO), the MPN Hub spoke to Gabriela Hobbs, Massachusetts General Hospital, Boston, US. We asked: How can we predict and reduce the risk of thrombosis in a patient with polycythemia vera (PV)?
How can we predict and reduce the risk of thrombosis in a patient with PV?
Patients with PV are at an increased risk of experiencing thrombotic complications, and cardiovascular events are the leading cause of death in these patients. Here, Gabriela Hobbs outlines the key risk factors and some of the driving biological processes for thrombosis in patients with PV.
A number of factors determine a patient's risk of thrombosis, including age and lifestyle factors. Here, Gabriela Hobbs describes how to manage patients on an individual basis to reduce the risk of thrombosis.
Related articles
Newsletter
Subscribe to get the best content related to MPN delivered to your inbox